Search results
SYS 0189136 LBL 00000naa^^22^^^^^^^^450 005 20230601135030.8 100 $a 20230601d2022 m y0sloy0103 ba 101 0-
$a eng 102 $a US 200 1-
$a Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial $f Carweg J. G., Stefanickova J. ... et al. 303 $a Popis urobený z citácie 463 -1
$1 200 1 $a Advances in Therapy $v Vol. 39 (2022), s. 2701–2716 701 -1
$3 sllk_un_auth*0058354 $a Carweg $b J. G. $4 070 701 -1
$3 sllk_un_auth*0002622 $a Štefaničková $b Jana $p Klinika oftalmológie LF UK a UN, Bratislava $4 070 801 -0
$a SK $b BA006 $c 20230601 $g AACR2 SYS 0189135 LBL 00000naa^^22^^^^^^^^450 005 20230601134453.9 100 $a 20230601d2019 m y0sloy0103 ba 101 0-
$a eng 102 $a US 200 1-
$a Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept $e The AQUA Study $f Carweg J. G., Stefanickova J. ... et al. 303 $a Popis urobený z citácie 463 -1
$1 200 1 $a Ophthalmology Retina $v Vol. 3, no. 7 (2019), s. 567-575 701 -1
$3 sllk_un_auth*0058354 $a Carweg $b J. G. $4 070 701 -1
$3 sllk_un_auth*0002622 $a Štefaničková $b Jana $p Klinika oftalmológie LF UK a UN, Bratislava $4 070 801 -0
$a SK $b BA006 $c 20230601 $g AACR2